207 related articles for article (PubMed ID: 29768755)
1. Metabolomic profiling in colorectal cancer: opportunities for personalized medicine.
Zheng X; Xie G; Jia W
Per Med; 2013 Sep; 10(7):741-755. PubMed ID: 29768755
[TBL] [Abstract][Full Text] [Related]
2. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y; Xie G; Jia W
J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?
van der Greef J; Hankemeier T; McBurney RN
Pharmacogenomics; 2006 Oct; 7(7):1087-94. PubMed ID: 17054418
[TBL] [Abstract][Full Text] [Related]
4. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
5. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
6. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
8. Towards personalized medicine of colorectal cancer.
Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
[TBL] [Abstract][Full Text] [Related]
9. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
10. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives.
Ullah I; Yang L; Yin FT; Sun Y; Li XH; Li J; Wang XJ
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428637
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics studies in gastrointestinal cancer: a systematic review.
Yu J; Zhao J; Zhang M; Guo J; Liu X; Liu L
Expert Rev Gastroenterol Hepatol; 2020 Jan; 14(1):9-25. PubMed ID: 31786962
[No Abstract] [Full Text] [Related]
13. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Approach in Probing Drug Candidates.
Liu C; Alessandro A; Xia Y
Curr Top Med Chem; 2017; 17(15):1741-1749. PubMed ID: 27848895
[TBL] [Abstract][Full Text] [Related]
15. Implementation of molecular phenotyping approaches in the personalized surgical patient journey.
Mirnezami R; Kinross JM; Vorkas PA; Goldin R; Holmes E; Nicholson J; Darzi A
Ann Surg; 2012 May; 255(5):881-9. PubMed ID: 22156927
[TBL] [Abstract][Full Text] [Related]
16. Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
Díaz-Beltrán L; González-Olmedo C; Luque-Caro N; Díaz C; Martín-Blázquez A; Fernández-Navarro M; Ortega-Granados AL; Gálvez-Montosa F; Vicente F; Pérez Del Palacio J; Sánchez-Rovira P
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33466323
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances and Challenges in Steroid Metabolomics for Biomarker Discovery.
Kotłowska A; Szefer P
Curr Med Chem; 2019; 26(1):29-45. PubMed ID: 29141530
[TBL] [Abstract][Full Text] [Related]
18. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
19. A Metabolomics-Based Screening Proposal for Colorectal Cancer.
Troisi J; Tafuro M; Lombardi M; Scala G; Richards SM; Symes SJK; Ascierto PA; Delrio P; Tatangelo F; Buonerba C; Pierri B; Cerino P
Metabolites; 2022 Jan; 12(2):. PubMed ID: 35208185
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
